Biotech Roundup: Deals Gone Wrong, Ethical Red Flags & Bay Goodbyes
Xconomy
JUNE 3, 2016
billion acquisition of San Diego’s Auspex Pharmaceuticals last year. —Edison, NJ-based Contravir Pharmaceuticals (NASDAQ: CTVR ) acquired privately held Ciclofilin Pharmaceuticals of San Diego to add another experimental drug for hepatitis B to its portfolio. Teva nabbed deutetrabenazine in its $3.2
Let's personalize your content